Ultragenyx Pharmaceutical | RARE - Interest Income

Stock Price
24.45
Daily Change
-0.24 -0.97%
Monthly
8.47%
Yearly
-46.59%
Q1 Forecast
23.33

Ultragenyx Pharmaceutical reported $5.79M in Interest Income for its fiscal quarter ending in June of 2025.





Interest Income Change Date
Acadia Pharmaceuticals USD 7.24M 658K Jun/2025
Agios Pharmaceuticals USD 14.51M 1.57M Jun/2025
Alnylam Pharmaceuticals USD 27.49M 1.19M Jun/2025
BioMarin Pharmaceutical USD 18.83M 186K Jun/2025
Insmed USD 765K 55K Sep/2024
Ionis Pharmaceuticals USD -0.66 0.29 Dec/2024
Kyowa Hakko Kirin JPY 2.54B 1.52B Jun/2024
MacroGenics USD 1.53M 114K Sep/2025
Moderna USD 81M 9M Jun/2025
Regeneron Pharmaceuticals USD 175.1M 300K Sep/2025
Sarepta Therapeutics USD 7.14M 3.05M Jun/2025
Ultragenyx Pharmaceutical USD 5.79M 1.04M Jun/2025
Vertex Pharmaceuticals USD 122.4M 1.5M Jun/2025